Rigel Pharmaceuticals, Inc. (RIGL)
25.95
-0.65
(-2.44%)
USD |
NASDAQ |
Mar 13, 16:00
25.92
-0.03
(-0.12%)
After-Hours: 20:00
Rigel Pharmaceuticals Total Liabilities (Quarterly) : 169.14M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Eli Lilly & Co. | 85.94B |
| Nektar Therapeutics | 190.57M |
| Ironwood Pharmaceuticals, Inc. | 658.74M |
| BioMarin Pharmaceutical, Inc. | 1.507B |
| Amicus Therapeutics, Inc. | 675.63M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 560.62M |
| Shareholders Equity (Quarterly) | 391.48M |
| Debt to Equity Ratio | 0.1362 |
| Current Ratio | 2.420 |
| Net Debt Paydown Yield | 0.18% |